The body that recommends what drugs can and cannot be paid for now says a drug once hailed as a breakthrough is not "cost effective".
A man from Lincolnshire who won his fight against prostate cancer has joined the ranks of those calling for Arbiraterone to remain available:
More top news
The prop has signed on a two-and-a-half year deal
The 39-year-old met the club's owners on Wednesday night and is understood to have told them of his decision to leave.
Students and staff at Leeds Beckett University are being told support is available after a popular student died in the Manchester attack.